News
Broad access to the fruits of NIH’s investments—whether in the form of data, results, or products—drives innovation. To advance this aim, NIH is launching a new policy to improve access to medical products developed from NIH-owned inventions. This policy emphasizes the importance of proactive
This technology identifies a new form of Cushing syndrome, "isolated micronodular adrenocortical disease" (iMAD), classified as a rare disease, as well as the role of PDE11A gene in this disease. Particular sequence variants of the PDE11A gene associated with abnormal or altered function of the gene
A new cancer vaccine developed by Merck makes use of a novel disease prevention strategy to protect against cervical cancer. The vaccine is based on research conducted at the NIH. Cervical cancer is the second most common form of cancer deaths in women worldwide. Each year roughly 233,000 women die
Six NIH technologies that have been developed into commercial products are featured in Federal Technology Transfer 2006, a new booklet from the Federal Laboratory Consortium (FLC). The booklet is a compilation of some of the most promising projects from FLC's member laboratories and agencies during